- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Patent holdings for IPC class C07D 213/75
Total number of patents in this class: 1450
10-year publication summary
125
|
97
|
103
|
95
|
102
|
84
|
87
|
68
|
74
|
46
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Vertex Pharmaceuticals Incorporated | 1597 |
34 |
Cytokinetics, Inc. | 277 |
33 |
Novartis AG | 10849 |
28 |
Bristol-myers Squibb Company | 4898 |
28 |
BASF SE | 20933 |
23 |
Nippon Soda Co., Ltd. | 895 |
19 |
Corteva Agriscience LLC | 2669 |
18 |
Boehringer Ingelheim International GmbH | 4650 |
17 |
Amgen Inc. | 4074 |
16 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
15 |
Syngenta Participations AG | 1903 |
14 |
Sanofi | 4055 |
14 |
Genentech, Inc. | 3976 |
13 |
Takeda Pharmaceutical Company Limited | 2713 |
13 |
Mitsui Chemicals Crop & Life Solutions,Inc. | 157 |
12 |
F. Hoffmann-La Roche AG | 7925 |
10 |
Centre National de La Recherche Scientifique | 10418 |
10 |
Sumitomo Chemical Company, Limited | 9046 |
10 |
ADT Pharmaceuticals, LLC | 13 |
10 |
VALO Health, Inc. | 172 |
10 |
Other owners | 1103 |